Your browser doesn't support javascript.
loading
Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.
Custodio, Ana; Moreno-Rubio, Juan; Aparicio, Jorge; Gallego-Plazas, Javier; Yaya, Ricardo; Maurel, Joan; Rodríguez-Salas, Nuria; Burgos, Emilio; Ramos, David; Calatrava, Ana; Andrada, Encarna; Díaz-López, Esther; Sánchez, Antonio; Madero, Rosario; Cejas, Paloma; Feliu, Jaime.
Afiliación
  • Custodio A; Medical Oncology Department, La Paz University Hospital, IdiPaz, Madrid, Spain. anabcustodio@gmail.com.
  • Moreno-Rubio J; Translational Oncology Unit, Medical Oncology Department, La Paz University Hospital, IdiPaz, Madrid, Spain.
  • Aparicio J; Medical Oncology Department, La Fe University Hospital, Valencia, Spain.
  • Gallego-Plazas J; Medical Oncology Department, General University Hospital, Elche (Alicante), Spain.
  • Yaya R; Medical Oncology Department, Valencian Oncology Institute, Valencia, Spain.
  • Maurel J; Medical Oncology Department, Clinic University Hospital, Barcelona, Spain.
  • Rodríguez-Salas N; Medical Oncology Department, La Paz University Hospital, IdiPaz, Madrid, Spain.
  • Burgos E; Pathology Department, La Paz University Hospital, IdiPaz, Madrid, Spain.
  • Ramos D; Pathology Department, La Fe University Hospital, Valencia, Spain.
  • Calatrava A; Pathology Department, Valencian Oncology Institute, Valencia, Spain.
  • Andrada E; Pathology Department, General University Hospital, Elche (Alicante), Spain.
  • Díaz-López E; Translational Oncology Unit, Medical Oncology Department, La Paz University Hospital, IdiPaz, Madrid, Spain.
  • Sánchez A; Medical Oncology Department, Puerta de Hierro University Hospital, Madrid, Spain.
  • Madero R; Biostatistics Unit, La Paz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain.
  • Cejas P; Translational Oncology Unit, Medical Oncology Department, La Paz University Hospital, IdiPaz, Madrid, Spain.
  • Feliu J; Medical Oncology Department, La Paz University Hospital, IdiPaz, Madrid, Spain.
Mol Cancer Ther ; 13(9): 2226-37, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24980946
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organoplatinos / Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2014 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organoplatinos / Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2014 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos